Related Experiment Video
Updated: Mar 26, 2026

Production and Purification of Baculovirus for Gene Therapy Application
Published on: April 9, 2018
Generation of Envelope-Modified Baculoviruses for Gene Delivery into Mammalian Cells
1Roche Pharma AG, Emil-Barell-Str. 1, 79639, Grenzach-Wyhlen, Germany. christian@doktorhofmann.de.
Abstract:
Genetically modified baculoviruses can efficiently deliver and express genes in mammalian cells. The major prerequisite for the expression of a gene transferred by baculovirus is its control by a promoter that is active in mammalian cells. This chapter describes methods for producing second generation baculovirus vectors through modification of their envelope. Envelope modified baculoviruses offer additional new applications of the system, such as their use in in vivo gene delivery, targeting, and vaccination. Methods of generating a recombinant baculovirus vector with a modified envelope and its amplification and purification, including technical scale production, are discussed. A variety of notes give clues regarding specific technical procedures. Finally, methods to analyze the virus and transduction procedures are presented.

